Skip to content
Clinical Trials – home
SwedenBack to Sweden

Clinical trials in Linkoping – page 13

180 clinical trials in Linkoping, Sweden across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

SwedenOur site in SwedenKliniska-Provningar.se(opens in a new tab)
Linkoping at a glance
180
clinical trials
  • Research sites3
Type of trial
Recruitment status
Quick filters

180 trials in Linkoping

Open in trial search

Study on the Safety and Effectiveness of Betula Pollen Extract for Children and Adolescents Aged 5-17 with Birch Pollen Allergies and Possible Asthma

Registered drug
Countries:SwedenSweden
  • Participants:0–17 years
  • Substances:Betula Pollen Extract
  • Sponsor:Stallergenes

Colitis ulcerative

Not recruiting

Study on the Effects of Guselkumab and Golimumab for Patients with Moderate to Severe Ulcerative Colitis

Investigational
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Golimumab
  • Sponsor:Janssen Cilag International

Facial paresis

Not recruiting

Study on Betamethasone Sodium Phosphate for Treating Acute Facial Nerve Palsy in Children

Registered drug
Countries:SwedenSweden
  • Participants:0–17 years
  • Sponsor:Region Dalarna

Study of Datopotamab Deruxtecan, Durvalumab, and Carboplatin for Advanced Non-Small Cell Lung Cancer in Patients Without Actionable Genomic Alterations

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:AstraZeneca AB

Study of ExPEC9V vaccine for preventing invasive E.

Investigational
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:ECOO15
  • Sponsor:Janssen Vaccines & Prevention B.V.

Asthma

Not recruiting

Study Comparing Depemokimab, Mepolizumab, and Benralizumab for Adults and Adolescents with Severe Eosinophilic Asthma

Registered drug
Countries:SwedenSweden
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Benralizumab
  • Sponsor:Glaxosmithkline Research & Development Limited

Study on the Effectiveness and Safety of Osimertinib for Patients with Stage IB-IIIA Non-Small Cell Lung Cancer After Tumor Removal

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Osimertinib
  • Sponsor:AstraZeneca AB

Infertility

Not recruiting

Study on Vaginal Progesterone for Improving Live Birth Rates in Women with Infertility Undergoing Frozen/Thawed IVF Natural Cycles

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Progesterone
  • Sponsor:Vaestra Goetalandsregionen

Study of ibrutinib and venetoclax combination therapy for patients with relapsed or refractory chronic lymphocytic leukemia who have adequate kidney function

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Ibrutinib
  • Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting

Study on the Effects of Metoprolol Tartrate for Patients with Chronic Obstructive Pulmonary Disease (COPD) Without Cardiovascular Disease

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Metoprolol Tartrate
  • Sponsor:Region Oerebro Laen

C3 glomerulopathy

Not recruiting

Study Comparing Aliskiren and Enalapril for Patients with C3 Glomerulopathy

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Aliskiren
  • Sponsor:Region Skane

Study on the Safety and Effectiveness of Diamyd and Colecalciferol for Adolescents and Adults with Recently Diagnosed Type 1 Diabetes

Registered drug
Countries:SwedenSweden
  • Participants:0–17 years · 18–64 years
  • Substances:Colecalciferol
  • Sponsor:Diamyd Medical AB

Other cities in Sweden

The busiest research cities in the country

All 66 cities in Sweden

Clinical research in Linkoping

What the registry says about research in the country

01 Cardiovascular & Metabolic Research

Groundbreaking studies focusing on atrial fibrillation prevention and treatment of chronic kidney disease with hypertension. Research includes novel therapies for stroke prevention and innovative drug combinations for metabolic conditions.

  • Stroke Prevention Trials
  • Hypertension Management
  • Metabolic Disorders

Current studies evaluate new anticoagulants and combination therapies for better patient outcomes.

02 Oncology Studies

Comprehensive research into various cancer types, including lymphocytic leukemia, testicular cancer, and esophageal carcinoma. Studies focus on optimizing treatment sequences and exploring new therapeutic approaches.

  • Hematological Malignancies
  • Solid Tumors
  • Pediatric Oncology

Investigations include both conventional and innovative treatment strategies.

03 Neurological & Mental Health

Innovative research examining prolonged grief disorder and major depressive disorder. Studies investigate novel therapeutic approaches and hormone effects on decision-making processes.

  • Depression Treatment
  • Behavioral Studies
  • Hormone Research

Research combines pharmacological interventions with behavioral assessments.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.